Volume 6, Issue 4 (2020)
IEM 2020, 6(4): 269-275 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Sadat S S, Ahani Azari A. Frequency of Multidrug-Resistant, Extensively Drug-Resistant, and Pandrug-Resistant Phenotypes among Clinical Isolates of Staphylococcus aureus. IEM 2020; 6 (4) :269-275
URL: http://iem.modares.ac.ir/article-4-45757-en.html
URL: http://iem.modares.ac.ir/article-4-45757-en.html
1- Department of Microbiology, Gorgan Branch, Islamic Azad University, Gorgan, Iran.
2- Department of Microbiology, Gorgan Branch, Islamic Azad University, Gorgan, Iran , ania_783@yahoo.com
2- Department of Microbiology, Gorgan Branch, Islamic Azad University, Gorgan, Iran , ania_783@yahoo.com
Abstract: (1763 Views)
Background: In recent years, the widespread prevalence of Multidrug-Resistant (MDR) Staphylococcus aureus strains and the increase in the number of Extensively Drug-Resistant (XDR) and Pandrug-Resistant (PDR) phenotypes amongst S. aureus strains have become one of the greatest challenges. This study aimed to determine the incidence of MDR, XDR, and PDR phenotypes in S. aureus strains in a teaching hospital in Gorgan, Golestan province, Iran.
Materials & Methods: Clinical samples of blood, urine, wound, and sputum were collected from all hospitalized patients during April to June 2019. S. aureus strains were identified using conventional biochemical methods, and antibiotic susceptibility assessment was performed by Kirby-Bauer disc diffusion method.
Findings: A total of 73 isolates were identified as S. aureus. The majority of S. aureus isolates were collected from wound specimens (31 out of 73). Most of the isolates were recovered from internal ward (35 out of 73), followed by intensive care unit (ICU) (16 out of 73). The highest susceptibility was observed to glycopeptides category (100%), and the lowest susceptibility was observed to erythromycin (54.7%), followed by cefoxitin (49.3%). Out of the 73 isolates, 32 (43.8%) were found to be methicillin-resistant S. aureus (MRSA) isolates. Among MRSA isolates, 96.8 and 12.5% were MDR and XDR, respectively. All of the MRSA isolates, were susceptible to vancomycin. No PDR phenotype was observed among the isolates as all of them were sensitive to vancomycin (100%).
Conclusion: Based on the obtained results, the highest and lowest antibiotic resistance was observed against erythromycin and vancomycin, respectively, which is consistent with similar studies conducted in the country. Therefore, these antibiotics should not be used in the empirical therapy of S. aureus infections
Materials & Methods: Clinical samples of blood, urine, wound, and sputum were collected from all hospitalized patients during April to June 2019. S. aureus strains were identified using conventional biochemical methods, and antibiotic susceptibility assessment was performed by Kirby-Bauer disc diffusion method.
Findings: A total of 73 isolates were identified as S. aureus. The majority of S. aureus isolates were collected from wound specimens (31 out of 73). Most of the isolates were recovered from internal ward (35 out of 73), followed by intensive care unit (ICU) (16 out of 73). The highest susceptibility was observed to glycopeptides category (100%), and the lowest susceptibility was observed to erythromycin (54.7%), followed by cefoxitin (49.3%). Out of the 73 isolates, 32 (43.8%) were found to be methicillin-resistant S. aureus (MRSA) isolates. Among MRSA isolates, 96.8 and 12.5% were MDR and XDR, respectively. All of the MRSA isolates, were susceptible to vancomycin. No PDR phenotype was observed among the isolates as all of them were sensitive to vancomycin (100%).
Conclusion: Based on the obtained results, the highest and lowest antibiotic resistance was observed against erythromycin and vancomycin, respectively, which is consistent with similar studies conducted in the country. Therefore, these antibiotics should not be used in the empirical therapy of S. aureus infections
Article Type: Original Research |
Subject:
Bacteriology
Received: 2020/09/5 | Accepted: 2020/10/17 | Published: 2020/11/20
Received: 2020/09/5 | Accepted: 2020/10/17 | Published: 2020/11/20
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |